A Program Announcement from:   Pharmaceutical Executive  
         
 
 
         
  POST-APPROVAL SUMMIT®. April 28-29, 2009. Conference Center at Harvard Medical School.  
 

The Post-Approval Summit is only two months away! The Summit agenda will focus on post-approval, safety, comparative effectiveness, and real-world data from real-world studies.

Day two of the Summit will address the pressing issue of measuring effectiveness with real-world data and comparative effectiveness. Sessions will begin with discussion from Dr. Gail Wilensky, Senior Fellow of Project Hope, on the political and economic forces driving the development of a comparative effectiveness institute and new initiatives in implementing evidence-based data and decision making.

Following Dr. Wilensky's commentary, presentations will address the industry and payer perspectives on challenges and benefits of conducting comparative effectiveness research, obtaining and developing evidence for reimbursement, and evaluating evidence for formulary decision making. Speakers covering these topics include:

  • Professor Sir Michael Rawlins, Chairman for the National Institute for Health and Clinical Excellence (NICE)
  • Gilbert J. L'Italien, Sc.D, Group Director in Health Outcomes Research at Bristol-Myers Squibb, Adjunct Assistant Professor, Yale University School of Medicine
  • Dr. Carolyn Clancy, Director at the Agency for Healthcare Research and Quality (AHRQ)
  • Dr. Richard Toselli, Vice President of Evidence Based Medicine in Medical Devices and Diagnostics at Johnson & Johnson
  • Dr. Fadia T. Shaya, Associate Professor and Associate Director at the Center on Drugs and Public Policy at the University of Maryland School of Pharmacy, Pharmaceutical Health Services Research
  • Dr. Daniel Winn, Vice President and Senior Medical Officer at CareFirst BlueCross Blueshield
  • Dr. Sean Tunis, Founder and Director of the Center for Medical Technology Policy

Please visit the Summit website to view the full agenda with confirmed speakers. For more information or to register, please click here or call 617-621-6426.

We sincerely hope you will be able to attend!

Best Regards,

The Committee for the Post-Approval Summit
201 Broadway, Cambridge, MA 02139
Tel: (617) 621-6426
Fax: (617) 621-1620
E-mail the committee
 
         
 

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser. To opt-out, click here.